{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:58:08Z","timestamp":1790769488594,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","award":["BO\/00359\/22"],"award-info":[{"award-number":["BO\/00359\/22"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Nemzeti Kutat\u00e1si \u00e9s Technol\u00f3giai Hivatal","doi-asserted-by":"publisher","award":["TKP-EGA-29"],"award-info":[{"award-number":["TKP-EGA-29"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtha.2026.09.001","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:05:57Z","timestamp":1788761157000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet spleen tyrosine kinase promotes solid tumor metastasis via thromboxane A2-mediated immunosuppression"],"prefix":"10.1016","author":[{"given":"Luca F.","family":"S\u00e1ndor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"M\u00f3csai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-6752","authenticated-orcid":false,"given":"D\u00e1vid S.","family":"Gy\u0151ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.09.001_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtha.2026.09.001_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.09.001_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2026.09.001_bib4","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0049-3848(14)50025-4","article-title":"Mechanistic explanation for platelet contribution to cancer metastasis","volume":"133","author":"Stegner","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.001_bib5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","article-title":"The initial hours of metastasis: the importance of cooperative host\u2013tumor cell interactions during hematogenous dissemination","volume":"2","author":"Labelle","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtha.2026.09.001_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ccell.2017.07.001","article-title":"Intravascular survival and extravasation of tumor cells","volume":"32","author":"Strilic","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtha.2026.09.001_bib7","first-page":"1295","article-title":"Lysis of tumor cells by natural killer cells in mice is impeded by platelets","volume":"59","author":"Nieswandt","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtha.2026.09.001_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","article-title":"Platelet\u2013cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation","volume":"143","author":"Jurasz","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtha.2026.09.001_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtha.2026.09.001_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","article-title":"Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor","volume":"24","author":"Schumacher","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtha.2026.09.001_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10555-017-9673-1","article-title":"Platelets and cancer angiogenesis nexus","volume":"36","author":"Wojtukiewicz","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jtha.2026.09.001_bib12","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood-2009-10-247296","article-title":"Deadly allies: the fatal interplay between platelets and metastasizing cancer cells","volume":"115","author":"Erpenbeck","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.001_bib13","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1073\/pnas.0700625104","article-title":"Platelet glycoprotein Ib alpha supports experimental lung metastasis","volume":"104","author":"Jain","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.09.001_bib14","first-page":"1146","article-title":"Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3","volume":"135","author":"Mammadova-Bach","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.001_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12885-024-12194-w","article-title":"The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis","volume":"24","author":"Sheng","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtha.2026.09.001_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"M\u00f3csai","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2026.09.001_bib17","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ni1407","article-title":"Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs","volume":"7","author":"M\u00f3csai","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtha.2026.09.001_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(02)00303-5","article-title":"Syk is required for integrin signaling in neutrophils","volume":"16","author":"M\u00f3csai","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2026.09.001_bib19","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/art.27438","article-title":"Genetic deficiency of Syk protects mice from autoantibody-induced arthritis","volume":"62","author":"Jakus","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtha.2026.09.001_bib20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fimmu.2019.00937","article-title":"Hematopoietic or osteoclast-specific deletion of Syk leads to increased bone mass in experimental mice","volume":"10","author":"Csete","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.09.001_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.tips.2024.08.006","article-title":"New insights into SYK targeting in solid tumors","volume":"45","author":"Joshi","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jtha.2026.09.001_bib22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/35021086","article-title":"The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells","volume":"406","author":"Coopman","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.09.001_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/iid3.449","article-title":"Comprehensive analysis of Syk gene methylation in colorectal cancer","volume":"9","author":"Bu","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jtha.2026.09.001_bib24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.0022-202X.2005.23685.x","article-title":"The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells","volume":"124","author":"Hoeller","year":"2005","journal-title":"Invest Dermatol"},{"key":"10.1016\/j.jtha.2026.09.001_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/0008-5472.CAN-14-0629","article-title":"SYK is a candidate kinase target for the treatment of advanced prostate cancer","volume":"75","author":"Ghotra","year":"2015","journal-title":"Cancer Res"},{"issue":"Suppl 5","key":"10.1016\/j.jtha.2026.09.001_bib26","article-title":"Co-expression network analysis identifies spleen tyrosine kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer","volume":"7","author":"Udyavar","year":"2013","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.jtha.2026.09.001_bib27","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/0008-5472.CAN-13-2104","article-title":"Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma","volume":"74","author":"Hong","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtha.2026.09.001_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96660-w","article-title":"Inflammatory signaling pathways play a role in SYK inhibitor resistant AML","volume":"15","author":"Tausch","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2026.09.001_bib29","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-22-3645","article-title":"Syk inhibition reprograms tumor-associated macrophages and overcomes gemcitabine-induced immunosuppression in pancreatic ductal adenocarcinoma","volume":"83","author":"Rohila","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtha.2026.09.001_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148317","article-title":"Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma","volume":"14","author":"Rohila","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.09.001_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1535-7163.MCT-19-0947","article-title":"Macrophage Syk-PI3K\u03b3 inhibits antitumor immunity: SRX3207, a novel dual Syk-PI3K inhibitory chemotype relieves tumor immunosuppression","volume":"19","author":"Joshi","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtha.2026.09.001_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-017-0512-1","article-title":"Syk inhibitors in clinical development for hematological malignancies","volume":"10","author":"Liu","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtha.2026.09.001_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ni893","article-title":"Essential role of Src-family protein tyrosine kinases in NF-\u03baB activation during B cell development","volume":"4","author":"Saijo","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtha.2026.09.001_bib34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2006-04-020362","article-title":"Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo","volume":"109","author":"Tiedt","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.001_bib35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1084\/jem.194.8.1151","article-title":"Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow","volume":"194","author":"Hao","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtha.2026.09.001_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2026.09.001_bib37","first-page":"954","article-title":"Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease","volume":"12","author":"Guy","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jtha.2026.09.001_bib38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1172\/JCI121985","article-title":"Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2","volume":"129","author":"Lucotti","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.09.001_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120631","article-title":"Compensation between CSF1R+ macrophages and FOXP3+ Treg cells drives resistance to tumor immunotherapy","volume":"3","author":"Gyori","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtha.2026.09.001_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113936","article-title":"De novo steroidogenesis in tumor cells drives bone metastasis and osteoclastogenesis","volume":"43","author":"Sandor","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtha.2026.09.001_bib41","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/09537104.2018.1528345","article-title":"Blood collection, platelet isolation and measurement of platelet count and size in mice\u2014a practical guide","volume":"30","author":"Aurbach","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2026.09.001_bib42","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2008-07-166439","article-title":"Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk","volume":"113","author":"Podolanczuk","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.001_bib43","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/art.23992","article-title":"Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial","volume":"58","author":"Weinblatt","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtha.2026.09.001_bib44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jtha.2026.09.001_bib45","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.001_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2022.2131751","article-title":"Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib","volume":"34","author":"Cooper","year":"2023","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2026.09.001_bib47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/bdra.20505","article-title":"Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing","volume":"85","author":"Clemens","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.jtha.2026.09.001_bib48","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/jm5018863","article-title":"Discovery and profiling of a selective and efficacious Syk inhibitor","volume":"58","author":"Thoma","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.jtha.2026.09.001_bib49","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/jm500228a","article-title":"Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase","volume":"57","author":"Currie","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.jtha.2026.09.001_bib50","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2014-08-595934","article-title":"An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia","volume":"125","author":"Sharman","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.001_bib51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2005.01.040","article-title":"An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment","volume":"115","author":"Meltzer","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtha.2026.09.001_bib52","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1182\/blood-2010-03-274969","article-title":"PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model","volume":"117","author":"Reilly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.001_bib53","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity","volume":"640","author":"Yang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.09.001_bib54","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626005611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626005611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:18:31Z","timestamp":1790767111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626005611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S1538783626005611"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.09.001","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet spleen tyrosine kinase promotes solid tumor metastasis via thromboxane A2-mediated immunosuppression","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}